Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Galectin Therapeutic (GALT)

4.62 0.06 (1.32%)

05-21 16:00

Open:

4.56

Pre. Close:

4.56

High:

4.7

Low:

4.4

Volume:

397,284

Market Cap:

174M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.703 - 4.717

4.717 - 4.732

Low:

4.359 - 4.376

4.376 - 4.394

Close:

4.59 - 4.616

4.616 - 4.644

Technical analysis  (as of: 2018-05-21 4:29:32 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 5.55     One year: 6.48

Support:

Support1: 3.73    Support2: 3.10

Resistance:

Resistance1: 4.75    Resistance2: 5.55

Pivot:

3.73

Moving Averages:

MA(5): 4.36     MA(20): 3.64

MA(100): 4.32     MA(250): 3.09

MACD:

MACD(12,26): 0.13     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 86.06     %D(3): 76.70

RSI:

RSI(14): 66.57

52-Week:

High: 6.74  Low: 1.28  Change(%): 97.4

Average Vol(K):

3-Month: 48576  10-Days 73974

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
GALT has closed below upper band by 5.2%. Bollinger Bands are 13.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-20T20:24:19-04:00
Week 21 Breakout Forecast: Short-Term Picks To Give You An Edge

2018-05-15T10:00:00-04:00
Your Daily Pharma Scoop: Galectin Phase 3 Trial, Acer NDA, Chiasma SPA Amendments

2018-05-14T12:46:32-04:00
Midday Gainers / Losers (05/14/2018)

2018-05-14T09:24:21-04:00
Galectin to advance NASH candidate GR-MD-02 into Phase 3

2018-05-11T16:13:44-04:00
Galectin Therapeutics beats by $0.01

2018-05-02T10:47:42-04:00
Cirius Therapeutics completes enrollment in mid-stage study of lead candidate in NASH

2018-04-20T07:43:03-04:00
Key events next week - healthcare

2018-04-10T12:38:30-04:00
Galectin Therapeutics (GALT) Presents At H. C. Wainwright Global Life Sciences Conference - Slideshow

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

37.57

Shares Float (M)

29.95

% Held by Insiders

20.30

% Held by Institutions

9.70

Shares Short (K)

2575

Shares Short Prior Month (K)

1040

Stock Financials

EPS

-0.490

EPS Est. Current Year

-0.530

EPS Est. Next Year

-0.520

EPS Est. Next Quarter

-0.130

Forward EPS

-0.690

Book Value (p.s.)

103.910

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-175.1

Return on Equity (ttm)

740.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.369

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.89

Levered Free Cash Flow (M)

-10.17

atoplab.com

Valuation

P/E

-9.43

P/E Growth Ratio

0.01

P/BV

0.04

P/S

P/CF

-10.92

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-03-23

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.